pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 1
Cerewint
Alzheimer's Disease
Regeneration Biomedical Inc
0 catalysts
Preclinical
Ceruloplasmin Project
Aceruloplasminemia
Kedrion SpA
0 catalysts
Marketed
Chenodiol Mirum
Chenodal (chenodiol)
Gall Stone
$MIRMMirum Pharmaceuticals, Inc.
0 catalysts
Preclinical
← prev
page 75 of 231
next →
131
Pain89
Neurology1
Chewell
Substance (Drug) Abuse
$IXHLIncannex Healthcare Inc.
0 catalysts
Marketed
Chewtadzy
Chewtadzy (tadalafil)
Storage Symptoms of Benign Prostatic Hyperplasia
$ANIPANI PHARMACEUTICALS INC
0 catalysts
Preclinical
Chronic Pain (CP)
Pain
GB Sciences Inc
0 catalysts
Phase 1
CodaVax-RSV
Respiratory Syncytial Virus (RSV) Infections
Codagenix Inc
0 catalysts
Marketed
Comirnaty KP.2
Omicron KP.2-adapted monovalent COVID-19 vaccine
Coronavirus Disease 2019 (COVID-19)
BioNTech US Inc
0 catalysts
Marketed
Comirnaty LP.8.1
Coronavirus Disease 2019 (COVID-19)
$PFEPFIZER INC
0 catalysts
Marketed
Concerta ER
Methylphenidate Hydrochloride Teva (methylphenidate hydrochloride)
Attention Deficit Hyperactivity Disorder (ADHD)
Teva Pharmaceuticals USA Inc
0 catalysts
Phase 1
Corlicyte
Diabetic Foot Ulcers
Cellresearch Corp Pte Ltd
0 catalysts
Phase 3
Coronavirus Disease 2019 (COVID-19) + influenza vaccine
Coronavirus Disease 2019 (COVID-19)
$PFEPFIZER INC
0 catalysts
Marketed
Coronavirus Disease 2019 (COVID-19) KP.2 vaccine
Spikevax KP.2
Coronavirus Disease 2019 (COVID-19)
$MRNAModerna, Inc.
0 catalysts
Marketed
Coronavirus Disease 2019 (COVID-19) vaccine 1
Covid-19 Vaccine (mivalsecovatein [INN])
Coronavirus Disease 2019 (COVID-19)
$NVAXNOVAVAX INC
0 catalysts
Preclinical
Coronavirus Disease 2019 (COVID-19) vaccines
Coronavirus Disease 2019 (COVID-19)
University of Florida
0 catalysts
Marketed
Coronavirus Disease 2019 (SARS-CoV-2) vaccine 2
Spikevax Omicron XBB.1.5
Coronavirus Disease 2019 (COVID-19)
$MRNAModerna, Inc.
0 catalysts
Marketed
Cortifoam
Cortifoam (hydrocortisone acetate)
Proctitis
Mylan Specialty LP
0 catalysts
Preclinical
Culnexin Inhibitors
Triple-Negative Breast Cancer (TNBC)
Culnexin Therapeutics LLC
0 catalysts
Marketed
Cutaquig
Cutaquig (immune globulin (human))
Primary Immune Deficiency (PID)
$PFEPFIZER INC
0 catalysts
Phase 2
CybroCell
Degenerative Disc Disease
$FBLGFibroBiologics, Inc.
0 catalysts
Marketed
Cyclobenzaprine Hydrochloride Teva
Cyclobenzaprine Hydrochloride (cyclobenzaprine hydrochloride)
Muscle Spasm
Pliva Inc (Inactive)
0 catalysts
Marketed
Cyfendus
Anthrax
$EBSEmergent BioSolutions Inc.
0 catalysts
Preclinical
Cyto-111
Botulism
CytoDel Inc
0 catalysts
Phase 2
Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK)
Refractory Acute Myeloid Leukemia
Cincinnati Children's Hospital Medical Center
0 catalysts
Phase 2
D-0120
Gouty Arthritis (Gout)
InventisBio Co Ltd
0 catalysts
Phase 1
D-121
Visceral Leishmaniasis (Kala-Azar)
Oblita Therapeutics BVBA
0 catalysts
Marketed
D-Penamine
Depen (penicillamine)
Rheumatoid Arthritis
Mylan Specialty LP
0 catalysts
Preclinical
D-Psilocybin
Major Depressive Disorder
Lennham Pharmaceuticals Inc
0 catalysts
Phase 2
D2C7-IT
Glioblastoma Multiforme (GBM)
Istari Oncology Inc
0 catalysts
Phase 1
D3L-001
Gastric Cancer
D3 Bio Inc
0 catalysts